Farnesoid X receptor: a potential therapeutic target in multiple organs

被引:12
|
作者
Zhang, Chao [1 ]
Wang, Zixuan [1 ]
Feng, Qingqing [1 ]
Chen, Wei-Dong [2 ,3 ]
Wang, Yan-Dong [1 ]
机构
[1] Beijing Univ Chem Technol, Coll Life Sci & Technol, State Key Lab Chem Resource Engn, Beijing, Peoples R China
[2] Inner Mongolia Med Univ, Sch Basic Med Sci, Key Lab Mol Pathol, Hohhot, Inner Mongolia, Peoples R China
[3] Henan Univ, Peoples Hosp Hebi, Sch Med, Key Lab Receptors Mediated Gene Regulat & Drug Di, Kaifeng, Henan, Peoples R China
关键词
Farnesoid X receptor; Bile acid; Metabolic homeostasis; Signaling pathways; AGONIST OBETICHOLIC ACID; BILE-ACIDS; NUCLEAR RECEPTOR; BREAST-CANCER; PANCREATIC-CANCER; NONALCOHOLIC STEATOHEPATITIS; PROLIFERATION DEFECTS; PORTAL-HYPERTENSION; ESTROGEN-RECEPTOR; CELL-MIGRATION;
D O I
10.14670/HH-18-301
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Farnesoid X receptor (FXR), a member of the nuclear receptor family, is a common receptor found in the intestine and liver, and helps to maintain systemic metabolic homeostasis through regulating bile acid, glucose, lipid metabolism, and energy homeostatsis. In addition, FXR regulates the functions of various organs, such as liver, intestine, kidney, breast, pancreas, cardiovascular system and brain. FXR also plays a key role in regulation of gut-microbiota through mediating the various signaling pathways. Accordingly, FXR has become an attractive therapeutic target in a variety of diseases. This review combines classical and recent research reports to introduce the basic information about FXR and its important roles in various organs of the body.
引用
收藏
页码:1403 / 1414
页数:12
相关论文
共 50 条
  • [1] Farnesoid X receptor as a therapeutic target for dyslipidemia
    Evans, Mark J.
    Gardell, Stephen J.
    CLINICAL LIPIDOLOGY, 2009, 4 (05) : 587 - 594
  • [2] The farnesoid X receptor: a potential target for expanding the therapeutic arsenal against kidney disease
    Masaoutis, Christos
    Theocharis, Stamatios
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (02) : 107 - 116
  • [3] Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
    Li, Chao
    Yang, Jie
    Wang, Yu
    Qi, Yingzi
    Yang, Wenqing
    Li, Yunlun
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [4] The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases
    Kim, Dong-Hyun
    Park, Jung Sun
    Choi, Hoon-In
    Kim, Chang Seong
    Bae, Eun Hui
    Ma, Seong Kwon
    Kim, Soo Wan
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2023, 55 (02): : 304 - 312
  • [5] The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases
    Dong-Hyun Kim
    Jung Sun Park
    Hoon-In Choi
    Chang Seong Kim
    Eun Hui Bae
    Seong Kwon Ma
    Soo Wan Kim
    Experimental & Molecular Medicine, 2023, 55 : 304 - 312
  • [6] Pregnane X receptor is a target of farnesoid X receptor
    Jung, Diana
    Mangelsdorf, David J.
    Meyer, Urs A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (28) : 19081 - 19091
  • [7] Liver X receptor and farnesoid X receptor as therapeutic targets
    Rader, Daniel J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (11): : 15N - 19N
  • [8] The farnesoid X receptor: a novel drug target?
    Claudel, T
    Sturm, E
    Kuipers, F
    Staels, B
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (09) : 1135 - 1148
  • [9] Therapeutic potential of farnesoid X receptor agonists for modulating inflammation and periodontal regeneration
    Jie Huang
    Huang Zhang
    Xusheng Fan
    Yongwu Wang
    Clinical Oral Investigations, 29 (1)
  • [10] Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
    Zhou, Mengjiao
    Wang, Danfeng
    Li, Xiang
    Cao, Ying
    Yi, Chengxue
    Wiredu Ocansey, Dickson Kofi
    Zhou, Yuling
    Mao, Fei
    FRONTIERS IN PHARMACOLOGY, 2022, 13